Lantern Pharma

Lantern Pharma

Biotechnology, 1920 McKinney Ave, Dallas, Texas, 75201, United States, 11-50 Employees

lanternpharma.com

  • facebook
  • twitter
  • LinkedIn

Who is LANTERN PHARMA

Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action, and also rescuing or revitalizing abandon...

Read More

map
  • 1920 McKinney Ave, Dallas, Texas, 75201, United States Headquarters: 1920 McKinney Ave, Dallas, Texas, 75201, United States
  • 2013 Date Founded: 2013
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from LANTERN PHARMA

Lantern Pharma Org Chart and Mapping

Employees

Drew Sturtevant

Senior Associate, Scientific Affairs & Communications

Peter Carr

Principal Software Architect

Aditya Kulkarni

Senior Research Scientist & Program Manager

Nicole Leber

Investor Relations Associate

Ernest Kitt

Head of Clinical Operations

Kishor Bhatia

Chief Scientific Officer

Caleb Schimke

Cancer Pharmaceutical Researcher

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Lantern Pharma

Answer: Lantern Pharma's headquarters are located at 1920 McKinney Ave, Dallas, Texas, 75201, United States

Answer: Lantern Pharma's official website is https://lanternpharma.com

Answer: Lantern Pharma's revenue is $1 Million to $5 Million

Answer: Lantern Pharma's SIC: 2834

Answer: Lantern Pharma has 11-50 employees

Answer: Lantern Pharma is in Biotechnology

Answer: Lantern Pharma contact info: Phone number: Website: https://lanternpharma.com

Answer: Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action, and also rescuing or revitalizing abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials. Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability to appropriately stratify patient populations prior to enrollment, and also from the inability to fully elucidate mechanisms of action that can suggest potent combinations. Our approach which leverages our RADR platform helps to provide rapid, meaningful insight to both of these central problems in oncology. Lantern is focused on accelerating personalized cancer therapy development through the use of AI and genomic-based patient stratification.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access